THORACIC AND CARDIOVASCULAR SURGEON, cilt.56, sa.2, ss.93-98, 2008 (SCI-Expanded, Scopus)
Background: Currently the best prognostic indicator for resected non-small cell lung cancer (NSCLC) is the TNM stage. Moreover, certain histopathological properties of the tumor (such as lymphatic, vascular and perineural invasion) can help to predict the survival of the patients.